Zhitong Finance App News, Cornerstone Pharmaceutical-B (02616.HK) issued an announcement. The company was informed by CEO, President of R&D and Executive Director Yang Jianxin (Dr. Yang), other directors and senior management that they had purchased a total of 2,425 million shares on the open market in June 2026 (share holdings increased this time), of which Dr. Yang purchased 1,237,500 shares.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Cornerstone Pharmaceutical-B (02616.HK) issued an announcement. The company was informed by CEO, President of R&D and Executive Director Yang Jianxin (Dr. Yang), other directors and senior management that they had purchased a total of 2,425 million shares on the open market in June 2026 (share holdings increased this time), of which Dr. Yang purchased 1,237,500 shares.